These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3582640)

  • 21. Toxogonin and pralidoxime: kinetic comparison after intravenous administration to man.
    Sidell FR; Groff WA; Kaminskis A
    J Pharm Sci; 1972 Nov; 61(11):1765-9. PubMed ID: 4569114
    [No Abstract]   [Full Text] [Related]  

  • 22. MMB-4 pharmacokinetics in rabbits after intravenous and intramuscular administration.
    Woodard CL; Lukey BJ
    Drug Metab Dispos; 1991; 19(1):283-4. PubMed ID: 1673416
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect of acetylcysteine and dipyroxime on the immune reactions in acute dichloroethane poisoning].
    Zabrodskiĭ PF; Gryzunov AV
    Eksp Klin Farmakol; 1997; 60(1):47-9. PubMed ID: 9162285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current understanding of the application of pyridinium oximes as cholinesterase reactivators in treatment of organophosphate poisoning.
    Jokanović M; Stojiljković MP
    Eur J Pharmacol; 2006 Dec; 553(1-3):10-7. PubMed ID: 17109842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of acetylcholinesterase reactivator dosage on its effectiveness in the treatment of tabun poisoning in mice].
    Kassa J
    Ceska Slov Farm; 2004 Jan; 53(1):31-4. PubMed ID: 15065394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potency of several oximes to reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by paraoxon in vitro.
    Jun D; Musilova L; Kuca K; Kassa J; Bajgar J
    Chem Biol Interact; 2008 Sep; 175(1-3):421-4. PubMed ID: 18617161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The pharmacology of dipyroxime].
    Golikov SN; Shchekoldina VI; Simonova IG
    Farmakol Toksikol; 1972; 35(5):589-92. PubMed ID: 4652010
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of oxime efficacy in nerve agent poisoning: development of a kinetic-based dynamic model.
    Worek F; Szinicz L; Eyer P; Thiermann H
    Toxicol Appl Pharmacol; 2005 Dec; 209(3):193-202. PubMed ID: 15904945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutic effectiveness of atropine and dipyroxime].
    Khaitov RKh; Baĭmuradov TB; Kadyrov US
    Veterinariia; 1972 Nov; 11():86-7. PubMed ID: 4677483
    [No Abstract]   [Full Text] [Related]  

  • 30. [Experience in the use of 1 of the cholinesterase reactivators--dipyroxime for the treatment of mental disorders].
    Ramkhen VF
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1971 Dec; 71(12):1872-7. PubMed ID: 5143977
    [No Abstract]   [Full Text] [Related]  

  • 31. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K; Bajgar J
    Clin Toxicol (Phila); 2009 Jan; 47(1):72-6. PubMed ID: 18686075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. THE TOXICITY OF SOME CHOLINESTERASE REACTIVATING OXIMES.
    ALBANUS L; JAERPLID B; SUNDWALL A
    Br J Exp Pathol; 1964 Apr; 45(2):120-7. PubMed ID: 14140748
    [No Abstract]   [Full Text] [Related]  

  • 33. [Changes in the transverse striated musculature during treatment with the pesticide, Neguvon, and TMB-4 reactivator].
    Dzhirkolova T; Dishovski Kh; Rusev G
    Eksp Med Morfol; 1979; 18(1):31-5. PubMed ID: 436709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and pharmacodynamics of the oxime HI6 in dogs.
    Klimmek R; Eyer P
    Arch Toxicol; 1986 Dec; 59(4):272-8. PubMed ID: 3827595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of triclopyr (3,5,6-trichloro-2-pyridinyloxyacetic acid) in the beagle dog and rhesus monkey: perspective on the reduced capacity of dogs to excrete this organic acid relative to the rat, monkey, and human.
    Timchalk C; Nolan RJ
    Toxicol Appl Pharmacol; 1997 Jun; 144(2):268-78. PubMed ID: 9194410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro reactivation potency of some acetylcholinesterase reactivators against sarin- and cyclosarin-induced inhibitions.
    Kuca K; Cabal J; Jun D; Kassa J; Bartosová L; Kunesová G
    J Appl Toxicol; 2005; 25(4):296-300. PubMed ID: 16025528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comments on "Efficacy of two new asymmetric bispyridinium oximes (K-27 and K-48) in rats exposed to diisopropylfluorophosphate: comparison with pralidoxime, obidoxime, trimedoxime, methoxime, and HI 6".
    Theirmann H; Worek F; Eyer P
    Toxicol Mech Methods; 2009 May; 19(4):334; author reply 335. PubMed ID: 19778225
    [No Abstract]   [Full Text] [Related]  

  • 38. High-performance liquid chromatographic determination of the plasma concentration of K-27, a novel oxime-type cholinesterase reactivator.
    Tekes K; Hasan MY; Sheen R; Kuca K; Petroianu G; Ludányi K; Kalász H
    J Chromatogr A; 2006 Jul; 1122(1-2):84-7. PubMed ID: 16690067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mathematical analysis of transport phenomenon to the blood from the site of intramuscular injection with ampicillin in the rat.
    Kumasawa A; Watanabe M; Kunii O
    Jpn J Exp Med; 1986 Aug; 56(4):141-6. PubMed ID: 3820731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testing of antidotes for organophosphorus compounds: experimental procedures and clinical reality.
    Eyer P; Szinicz L; Thiermann H; Worek F; Zilker T
    Toxicology; 2007 Apr; 233(1-3):108-19. PubMed ID: 17010492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.